Clazosentan to overcome neuroslogical ischemia and infarction occurring after subarachnoid hermorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

Macdonald, RL.; Kassell, NF.; Mayer, S.; Ruefenacht, D.; Schmiedek, P.; Weidauer, S.; Frey, A.; Roux, S.; Pasqualin, A.; Raabe, A. (2008). Clazosentan to overcome neuroslogical ischemia and infarction occurring after subarachnoid hermorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke, 39(11), pp. 3015-3021. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/STROKEAHA.108.519942

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurosurgery

UniBE Contributor:

Frey, Andrea and Raabe, Andreas

ISSN:

0039-2499

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:04

Last Modified:

08 Jun 2016 10:46

Publisher DOI:

10.1161/STROKEAHA.108.519942

Web of Science ID:

000260427100018

URI:

https://boris.unibe.ch/id/eprint/27841 (FactScience: 112598)

Actions (login required)

Edit item Edit item
Provide Feedback